| scholarly article | Q13442814 |
| P50 | author | Hyun Jung Kim | Q88236971 |
| Eun Hye Choi | Q88236973 | ||
| Yeon Jung Lim | Q88236975 | ||
| Hong Ryang Kil | Q88236977 | ||
| P2093 | author name string | Hyun Jung Kim | |
| Hong Ryang Kil | |||
| Eun Hye Choi | |||
| Yeon Jung Lim | |||
| P2860 | cites work | Spontaneous platelet aggregation in Kawasaki disease using the particle counting method | Q79338485 |
| Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition) | Q81531506 | ||
| Platelet activation dynamics evaluated using platelet-derived microparticles in Kawasaki disease | Q86576887 | ||
| Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy | Q28213372 | ||
| Platelet microparticles: a wide-angle perspective | Q33706238 | ||
| Microparticles in cardiovascular diseases. | Q34221054 | ||
| Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study | Q34456208 | ||
| Function and clinical significance of platelet-derived microparticles | Q34496416 | ||
| A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome | Q34580488 | ||
| Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults | Q34662040 | ||
| Thrombocytosis: too much of a good thing? | Q34675322 | ||
| Cellular microparticles: a disseminated storage pool of bioactive vascular effectors | Q35838107 | ||
| Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases | Q37307308 | ||
| Modulation of monocyte-endothelial cell interactions by platelet microparticles | Q37387105 | ||
| Clinical relevance of microparticles from platelets and megakaryocytes | Q37782534 | ||
| Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation | Q37857372 | ||
| Platelets: key players in vascular inflammation | Q38038134 | ||
| Use of antiplatelet agents in sepsis: a glimpse into the future | Q38150551 | ||
| Management of coronary artery aneurysms using abciximab in children with Kawasaki disease. | Q39636928 | ||
| Coagulopathy and platelet activation in Kawasaki syndrome: Identification of patients at high risk for development of coronary artery aneurysms | Q40825705 | ||
| On the trail of microparticles | Q42877173 | ||
| Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements | Q44274318 | ||
| Different effects of various anti-GPIIb-IIIa agents on shear-induced platelet activation and expression of procoagulant activity | Q44563411 | ||
| Endothelial and platelet function in children with previous Kawasaki disease | Q45769728 | ||
| Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients. | Q50276497 | ||
| Microparticle detection in platelet products by three different methods. | Q51337712 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 1147-1153 | |
| P577 | publication date | 2017-07-01 | |
| P1433 | published in | Journal of Korean Medical Science | Q24039955 |
| P1476 | title | The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease | |
| P478 | volume | 32 |
| Q92538422 | Current State of Precision Medicine in Primary Systemic Vasculitides |
| Q47261379 | Is aspirin necessary in the acute phase of Kawasaki disease? |
| Q91638985 | Utility of color Doppler echocardiography combined with clinical markers in diagnosis and prediction of prognosis of coronary artery lesions in Kawasaki disease |
Search more.